Utility of Low Dose Vasopressin for Persistent Pulmonary Hypertension of Newborn with Catecholamine Refractory Shock

Khare, Chetan and Adhisivam, Bethou and Bhat, B. Vishnu and Vaishnav, Dheeraj (2021) Utility of Low Dose Vasopressin for Persistent Pulmonary Hypertension of Newborn with Catecholamine Refractory Shock. Indian Journal of Pediatrics, 88 (5). pp. 450-454. ISSN 0019-5456

Full text not available from this repository.

Abstract

Objective: To evaluate the effect of low dose vasopressin on the hemodynamics of neonates with persistent pulmonary hypertension and catecholamine refractory shock. Methods: This retrospective study was conducted in a level III NICU of a tertiary care teaching hospital, south India. Eighteen neonates with hypoxemic respiratory failure due to persistent pulmonary hypertension of newborn with catecholamine refractory shock were studied. Neonates were managed for hypotension with conventional inotropic support with the additional use of low dose vasopressin (LDV). Effect of vasopressin on oxygenation index (OI), blood pressure, duration of inotropic usage and survival was evaluated. Results: Mean OI was 38.2 ± 4.9, and mean blood pressure was 30.7 ± 5.3 mmHg before the start of vasopressin. Initiation of LDV (0.0003 ± 0.0001 IU/kg/min) for a median duration 36.4 ± 17.9 h was followed by a reduction in OI (p < 0.001), control of hypotension (p < 0.001), reduction in lactic acidosis (p < 0.001) and decline in inotropic support. Conclusions: In resource-restricted settings, LDV may be useful as a rescue therapy for persistent pulmonary hypertension of newborn with catecholamine refractory shock. © 2021 Elsevier B.V., All rights reserved.

Item Type: Article
Subjects: Nursing > Pediatric Nursing
Divisions: Medicine > Aarupadai Veedu Medical College and Hospital, Puducherry > Paediatrics
Depositing User: Unnamed user with email techsupport@mosys.org
Last Modified: 04 Dec 2025 07:09
URI: https://vmuir.mosys.org/id/eprint/3201

Actions (login required)

View Item
View Item